Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) has shared an update.
SMS Pharmaceuticals Limited announced that CARE Ratings Limited has reaffirmed and upgraded its credit ratings for the company’s bank facilities. The long-term bank facilities have been reaffirmed with a positive outlook, while the short-term bank facilities have been upgraded, reflecting the company’s strong operational and financial performance. This credit rating improvement is likely to enhance the company’s financial standing and could positively impact its ability to secure favorable financing terms, benefiting stakeholders and potentially strengthening its market position.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is known for its commitment to quality and innovation, serving both domestic and international markets.
Average Trading Volume: 82,553
Technical Sentiment Signal: Strong Buy
Current Market Cap: 29.14B INR
For a thorough assessment of SMSPHARMA stock, go to TipRanks’ Stock Analysis page.